Corporate Brochure
Corporate Video
Gallery
News & Updates
Home
About Akums
Company Profile
Formation
Mission and Vision
Leadership
Directors message
Leadership Team
Business Model
Awards and Accolades
Business Partners
Our Expertise
Manufacturing
Research & Development
Innovations
Quality
Regulatory
Units
Plant 1 (Solid Orals)
Plant 2 (Oral Liquids)
Plant 3 (Injectables)
Plant 4 (Hormonals)
Plant 5 (Ointment & Cosmetics)
Plant 6 (Maxcure Nutravedics Ltd)
Plant 7 (Pure and Cure)
Plant 8 (Malik Lifesciences)
Plant 9 (Pure Cure Guwahati)
Plant 10 (Akums Healthcare Ltd (Sidcul Kotdwar))
Centralised Stability Centre
Corporate Governance
Financial Statements
Shareholders Meetings
Corporate Social Responsibility
Environment Health & Safety
Disclosures
Global Presence
Careers
Working with us
Colors @ Akums
Current Openings
Events
Employee Recognition
Trainings
Gallery
News
Akums in News
Industry News
Blogs
Contact Us
Home
About Akums
Company Profile
Formation
Mission and Vision
Leadership
Directors message
Leadership Team
Business Model
Awards and Accolades
Business Partners
Our Expertise
Manufacturing
Research & Development
Innovations
Quality
Regulatory
Units
Plant 1 (Solid Orals)
Plant 2 (Oral Liquids)
Plant 3 (Injectables)
Plant 4 (Hormonals)
Plant 5 (Ointment & Cosmetics)
Plant 6 (Maxcure Nutravedics Ltd)
Plant 7 (Pure and Cure)
Plant 8 (Malik Lifesciences)
Plant 9 (Pure Cure Guwahati)
Plant 10 (Akums Healthcare Ltd (Sidcul Kotdwar))
Centralised Stability Centre
Corporate Governance
Financial Statements
Shareholders Meetings
Corporate Social Responsibility
Environment Health & Safety
Disclosures
Global Presence
Careers
Working with us
Colors @ Akums
Current Openings
Events
Employee Recognition
Trainings
Gallery
News
Akums in News
Industry News
Blogs
Contact Us
Akums in News
admin
2021-11-25T07:25:53+00:00
Healthcare Radius ( 08th Feb 2023) – Akums Launches Type 2 Diabetes Drug, Lobeglitazone
Read More
Medical Dialogues ( 06th Feb 2023) – Akums Drugs and Pharma Bags DCGI Nod to Unveil Type 2 Diabetes Drug Lobeglitazone in India
Read More
Biospectrum India ( 06th Feb 2023) – Akums receives DCGI approval for type 2 diabetes drug to improve insulin resistance
Read More
ET Healthworld ( 06th Feb 2023) – Akums gets DCGI nod to launch anti-diabetic drug Lobeglitazone in India
Read More
Express Pharma ( 06th Feb 2023) – Akums gets DCGI approval to launch Lobeglitazone for diabetes treatment in India
Read More
BW Healthcare World ( 06th Feb 2023) – Akums Receives DCGI Approval To Launch Diabetes Drug For Type 2 Diabetics
Read More
Money Control ( 06th Feb 2023) – Akums gets DCGI nod to launch drugs for uncontrolled diabetes in India
Read More
Financial Express (06th Feb 2023) – Akums Pharma gets DCGI approval to launch drug for type 2 diabetic patients
Read More
The Healthsite ( 02nd Feb 2023) – Health Budget 2023: Nothing Much For Women’s Healthcare
Read More
Healthcare Radius ( 02nd Feb 2023) – Budget Reactions: Industry Welcomes Union Budget 2023 Provisions
Read More
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
